Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm non-pagetic cortical bone

D.H. Gutteridge, R.W. Retallack, L.C. Ward, R.I. Price, G.O. Stewart, B.G.A. Stuckey, Richard Prince, G.N. Kent, C.I. Bhagat, R.I. Thompson, G.C. Nicholson

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    Bone mineral density (BMD) was measured at three sites (forearm, spine, and hip) using dual X-ray and single-photon absorptiometry in 68 patients with Paget’s disease before and after treatment with iv pamidronate. Patients were treated according to the severity of their disease; the mild category (Group I, hydroxyproline excretion (HypE)
    Original languageEnglish
    Pages (from-to)56-61
    JournalBone
    Volume32
    Issue number1
    DOIs
    Publication statusPublished - 2003

    Fingerprint Dive into the research topics of 'Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm non-pagetic cortical bone'. Together they form a unique fingerprint.

  • Cite this

    Gutteridge, D. H., Retallack, R. W., Ward, L. C., Price, R. I., Stewart, G. O., Stuckey, B. G. A., Prince, R., Kent, G. N., Bhagat, C. I., Thompson, R. I., & Nicholson, G. C. (2003). Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm non-pagetic cortical bone. Bone, 32(1), 56-61. https://doi.org/10.1016/S8756-3282(02)00925-0